Skip to main content

Peer Review reports

From: A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease

Original Submission
12 Aug 2019 Submitted Original manuscript
3 Nov 2019 Author responded Author comments - Pui Lin Chong
Resubmission - Version 2
3 Nov 2019 Submitted Manuscript version 2
9 Jan 2020 Reviewed Reviewer Report
7 Jul 2020 Reviewed Reviewer Report
18 Sep 2020 Reviewed Reviewer Report
28 Sep 2020 Reviewed Reviewer Report
29 Oct 2020 Author responded Author comments - Pui Lin Chong
Resubmission - Version 3
29 Oct 2020 Submitted Manuscript version 3
7 Dec 2020 Reviewed Reviewer Report
5 Feb 2021 Author responded Author comments - Pui Lin Chong
Resubmission - Version 4
5 Feb 2021 Submitted Manuscript version 4
Publishing
9 Feb 2021 Editorially accepted
1 Apr 2021 Article published 10.1186/s12876-021-01660-5

You can find further information about peer review here.

Back to article page